Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_4
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Other(3)

Detailed Status

unknown2
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 41 (50.0%)
N/A1 (50.0%)

Trials by Status

suspended133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
suspended

The Effect of Surfactant Administration on Cerebral Oxygenation

NCT01258517
unknownphase_4

The Effect of Mydriatic Eye Drops on Cerebral and Mesenteric Oxygenation in Preterm Infants

NCT01305720
unknownnot_applicable

Measurement of Cerebral and Peripheric Tissue Oxygenation in Anemic Preterm Infants Who Underwent Blood Transfusion

NCT01251068

Clinical Trials (3)

Showing 3 of 3 trials
NCT01258517

The Effect of Surfactant Administration on Cerebral Oxygenation

Suspended
NCT01305720Phase 4

The Effect of Mydriatic Eye Drops on Cerebral and Mesenteric Oxygenation in Preterm Infants

Unknown
NCT01251068Not Applicable

Measurement of Cerebral and Peripheric Tissue Oxygenation in Anemic Preterm Infants Who Underwent Blood Transfusion

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3